Homocysteine and all-cause mortality in hypertensive adults without pre-existing cardiovascular conditions
Benjamin Xu(Duke University), Yong Huo(Sun Yat-sen University), Lishun Liu(China Agricultural University), Xianhui Qin(Nanfang Hospital), Fan Fan Hou(Southern Medical University), Ziyi Zhou(Kunming University of Science and Technology), Yun Song(Novem (Netherlands)), Xiuli Shi(U.S. National Science Foundation), Ye Tian(U.S. National Science Foundation), Rui Gu(Wenzhou Medical University), Mingli He(Southern Medical University), Binyan Wang(Brigham and Women's Hospital), Yimin Cui(Peking University), Ningling Sun(Peking University), Ping Li(U.S. National Science Foundation), Yan Zhang(Nanchang University), Jianping Li(Binzhou Medical University), Hao Xue(The University of Texas MD Anderson Cancer Center), Yundai Chen(Chinese PLA General Hospital), Yefeng Cai(Southern Medical University), Min Zhao(Southern Medical University), Richard Xu(Johns Hopkins University), Changyan Wu(U.S. National Science Foundation), Xiangyi Kong(Capital Medical University), Jia Fu(U.S. National Science Foundation), Fang Chen(Nanjing Medical University), Xiao Huang(Wuhan Union Hospital), Genfu Tang(Anhui University), Xiaoshu Cheng(Nanchang University)
Cited by 27
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934